Preciously, exogenous administration is applied, but it is prone to in vivo metabolism, bone induction lasts less time, requires more amounts and costs much.

• 既往多采用外源性给药方法，但其在体内易被代谢，骨诱导时间短，用量大，需反复使用，且成本高。